Fifteen U.S. patents; two applications pending.
Fifteen U.S. patents; two applications pending.
Fluent in English and French. Permanent U.S. resident status.
BUSINESS DEVELOPMENT & ENGINEERING EXECUTIVE
Innovative and versatile leader with a unique breadth of demonstrated success and track record of revenue grossing engineered solutions for the medical device industry. A market focused, hands-on entrepreneur skilled at identifying and driving new business opportunities, securing customer loyalty and forging key relationships with physicians, device OEMs and other business partners. Demonstrated capacity for developing and executing strategic plans that will create sustainable competitive advantage, promote revenue growth and enhance shareholder value. A forward thinking negotiator with diverse U.S. and European management responsibilities encompassing all aspects of product innovation, engineering, sales & marketing, mergers & acquisitions, market development and manufacturing operations. An entrepreneurial executive with a strong ability to manage projects, deliver results and inspire fast paced results-oriented teams.
Memry Corporation, formerly a $56 million publicly traded company, leading provider of nitinol-based semi-finished products & components and high-end polymer extrusions to the minimally invasive and endovascular device industry. Acquired by SAES-Getters (Italy) in September 2008. SAES-Getters subsequently sold the extrusion business in February 2009.
Raychem Corp., formerly a $1.8 billion publicly traded global broad-based technology company, developer and manufacturer of high performance components and materials for defense electronics, telecommunications, energy and industrial applications. Acquired by Tyco International in 1999 after selling its Medical Division to Memry Corp. in 1996.
A management consulting entity helping medical device companies to identify, evaluate and profit from new business growth opportunities created by changing market dynamics, competitive landscapes and technologies. Strategic assessment of key alternatives such as of mergers, acquisitions, licensing, partnerships and alliances.
·Key member of the executive team that successfully marketed and sold the company to a strategic buyer in September 2008 generating a 75% increase to preannouncement stock price for shareholders. Provided seamless transition by training SAES-Getters executives to customer base, technical and manufacturing capabilities, engineering projects and pipeline.
·Envisioned company corporate strategy, initiated and spearheaded M&A activities resulting in the company’s first and immediately accretive acquisition in November 2004, a privately held high-end catheter extrusion company.
·Go-to expert on technology, medical market and device applications to support the executive, sales & marketing and engineering teams to hone in on a profitable niche market and bring distinctive value to the customers in it.
·Led the diversification and expansion of the company global activities by identifying, qualifying and championing activities and follow up for the products generating in excess of 70% of company yearly revenues.
·Directed a successful 2-year R&D collaboration program leading to the execution of an exclusive license agreement with a U.K. technology company for an anti-proliferative stent coating to expand the company’s current bare nitinol stent platform offering into $1 billion premium market segment.
·Reduced IP legal cost by more than $140K/year by realigning and streamlining company’s IP portfolio.
·Generated more than $3 million/year in short term revenues by spearheading a new 6-member strategic engineering team chartered with optimizing engineered product development and introduction cycle while maximizing customer responsiveness.
·Managed $4 million+ capital budget to set up and validate new state-of-the-art facility for laser cutting and post processing of self-expanding vascular stents. Coordinated and directed all development, validations, scale up and manufacturing activities for vascular stent-graft program for large medical OEM generating more than $6 million in immediate revenue, or 90% of total company sales growth for year 2000, and a steady $10+ million/year contribution subsequently.
·Improved operational efficiency by re-engineering and re-documenting manufacturing processes for the top 25 products resulting in a sustained reduction of scrap and rework by an average of 25%.
·Galvanized nitinol wire and tubing products pipeline into a prolific product development effort by closely bringing together sales, product development, process engineering and manufacturing activities resulting into 3 new product introductions and 2 product line extensions. Envisioned and implemented company-wide design review processes for new product and manufacturing equipment. Co-directed company ISO certification program.
·Fueled revenues from $11 to $27 million over a 3-year span by driving the creation of a direct sales & marketing organization and leveraging the strengths of a commissioned private label distributor.
·Shifted sales to the medical device industry to more than 70% of total company revenue by applying market and technology knowledge to new target applications and enhancing direct interaction with end-users.
·Secured $4 million in new implant business within a year by implementing a strategic solution-based opportunity qualification approach and competitive analysis.
·Mentored and provided professional development to direct reports leading to engineers’ and technicians’ promotions into respectively management and engineering positions.
·Created and built a medical device IP portfolio sold for $25 million in 1996 to a major medical device company by directing an incubator team targeting new product concepts for the minimally invasive surgery and cardiovascular markets. Brought projects along from concept to manufacturability creating a $6 million/year revenue stream since 1993. Designed and produced some of the first self-expanding nitinol stents.
·Created global market recognition of a newly created Raychem Medical Division by leading the team that pioneered the use of nitinol in innovative minimally invasive devices which triggered the execution of business agreements with a leading endo-surgery company generating revenues in excess of $3 million within the first year.
·Won the Leonardo New Horizon Award from the International Society for the Arts, Science & Technology (Berkeley, USA) for ‘Totem of the Future’, a 20-foot high shape memory sculpture changing shape with outside temperature (original idea by Jean-Marc Philippe).
·Invented and developed a novel electromagnetic interference shielding termination system for sonar detection cables of the French Navy reducing system weight by 50% and wire harnessing cost by 35%.
Additional Experience:Sr. Design Engineer- Aerospace Division. Shape memory fluid fitting systems and couplings (Swindon, UK - 1985); Development Engineer, Electronic Devices Division. Self-stripping and crimping military interconnection system (Pontoise, France - 1982 to 1984).
MSc.+1 equivalent, Mechanical Engineering & Material Science